vimarsana.com

Latest Breaking News On - Yuval shaked - Page 1 : vimarsana.com

AI tool helps doctors pick optimum cancer treatment for patients

An Israeli medtech company is using AI to help oncologists decide the best and most effective course of treatment for their cancer patients.

H efaOfer sharonYuval shakedIsrael institute of technologyWorld cancer research fundTechnology science lungInternational cancer microenvironmental societyCancer centerWellcome imagesChief scientific advisorIntegrated cancer centerIsrael institute

Align taps new EVP, managing director of iTero scanners

Align Technology has named Karim Boussebaa as its executive vice president and managing director of iTero scanner and services.

Karim boussebaaYuval shakedPhilips healthcareAlign technologyKarim boussebaaItero scanners

Align Technology, Inc : Align Technology Appoints Karim Boussebaa, EVP and MD of iTero Scanner and Services Business-Yuval Shaked to Leave Align End of 2023

Align Technology, Inc. (Nasdaq: ALGN), a leading global medical device company that designs, manufactures, and sells the Invisalign® system of clear aligners, iTero intraoral scanners, and exocad CAD/CAM

Karim boussebaaSarah johnsonJoe hoganYuval shakedSchwierige zeitenMadelyn valenteTechnology incZeno groupGe healthcareAlign technologyAlign technology presidentItero elementPhilips healthcarePhilips image guided therapy systemsStructural heartLike yuval

Align Technology Appoints Karim Boussebaa, EVP and MD of iTero Scanner and Services Business—Yuval Shaked to Leave Align End of 2023

Align Technology, Inc. , a leading global medical device company that designs, manufactures, and sells the Invisalign® system of clear aligners, iTero™ intraoral scanners, and exocad™. | February 8, 2023

Karim boussebaaJoe hoganYuval shakedTechnology incGe healthcareAlign technologyAlign technology presidentItero elementPhilips healthcarePhilips image guided therapy systemsStructural heartLike yuvalAlign digital platformTero exocad connectorNc stock exchangePress release

OncoHost to launch PROphet for NSCLC in the U S in 2023

OncoHost will launch PROphet in the U.S. for non-small cell lung cancer (NSCLC) patients in February 2023.

North carolinaUnited statesOfer sharonYuval shakedBishal gyawaliCancer research centerCenters for medicare medicaid servicesNational cancer instituteQueen university department of oncologyIsrael institute of technologyIntegrated cancer research centerIsrael instituteClinical oncologyNature reviews cancerUniversity departmentMedicaid services

vimarsana © 2020. All Rights Reserved.